본문 바로가기
KERD
논문KCI 등재

The enhancement of apoptosis by combined with proteasome inhibitorand DNA synthetic inhibitor in oral cancer

Ji-Eun Jung|Young-Hee Lee|Nan-Hee Lee|Eun-Jung Jhee|Ho-Keun Yi|Jung-Chang Lee|Hyun-Ju Moon
대한구강생물학회 (Korean Academy Of Oral Biology)|2008.03|International Journal of Oral Biology|제33권 제1호|pp. 25-31

2

조회

0

다운로드

3

인용

0

참고문헌

주제분류치의학

초록

Abstract

Inhibition of proteasome activity may reduce many types of cancer, so it's pathway is effective in cancer as well as in clinical fields. Here the author has carried out experiment targeting on the elevation of apoptosis in oral cancer cells by combination of proteasome inhibitor, lactacystin, and DNA replication inhibitor, etoposide. The growth of KB cells was measured by MTT methods and apoptosis was analyzed by DNA fragmentation and Hochest nucleus staining. The proteasome activity was analyzed by fluorescent tagged peptide and cellular protein expression was detected by Western hybridization. Though lactacystin and etoposide inhibited KB cell growth alone, but low combined doses inhibited cell growth more strongly and induced apoptosis. The proteasome activity was also seriously inhibited by the combination of both chemicals. Tumor suppressor proteins and apoptosis inducing proteins were highly increased under the combination of both chemicals. From above studies we can conclude that proteasome inhibitors may be used for the treatment of oral cancer and proteasome inhibitors with DNA replication inhibitors may be effective in clinical trials of oral cancer.

참고문헌 (23)

  1. Adachi, N., "Hypersensitivity of nonhomologous DNA end-joining mutants to VP-16 and ICRF-193: implications for the repair of topoisomerase IImediated DNA damage", Journal of Biological Chemistry, 278, pp.35897~35902 (2003)
  2. Adams, J., "Proteasome Inhibitors: A Novel Class of Potent and Effective Antitumor Agents", Cancer Research, 59, pp.2615~2622 (1999)
  3. Adams, J., "The proteasome: structure, function, and role in the cell", Cancer Treatment Reviews, 29, pp.3~9 (2003)
  4. Aghajanian, C., "A phase I trial of the novel proteasome inhibitor PS 341 in advanced solid tumor malignancies", Clinical Cancer Research, 8, pp.2505~2511 (2002)
  5. An, W. G., "Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1", CIP1, and induction of apoptosis are independent markers of proteasome inhibition, 2000, pp.14, 1276~1283
  6. Banerjee, D., "Potential of the proteasomal inhibitor MG-132 as an anticancer agent, alone and in combination", Anticancer Research, 21, pp.3941~3947 (2001)
  7. Bross, P.F., "Approval summary for bortezomib for injection in the treatment of multiple myeloma", Clinical Cancer Research, 10, pp.3954~3964 (2004)
  8. Ciechanover,A., "The ubiquitin-proteasome pathway", Cell, 79, pp.13~21 (1994)
  9. Cusack, J. C. Jr., "Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition", Cancer Research, 61, pp.3535~3540 (2001)
  10. Frankel, A., "Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341", Clinical Cancer Research, 6, pp.3719~3728 (2000)
  11. Hideshima, T., "The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells", Cancer Research, 61, pp.3071~3076 (2001)
  12. Jeremias, I., "Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells", Blood, 91, pp.4624~4631 (1998)
  13. LeBlanc, R., "Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model", Cancer Research, 62, pp.4996~5000 (2002)
  14. Licitra, L., "Major and minor salivary glands tumours", Critical Reviews in Oncology Hematology, 45, pp.215~225 (2003)
  15. Lonial, S., "The enhancement of apoptosis by combined with proteasome inhibitor and DNA synthetic inhibitor in oral cancer 31 Esseltine, D.L., Anderson, J., Xiao, H., Heffner, L.T., Anderson, K. C.: Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma", Blood, 106, pp.3777~3784 (2005)
  16. Omura, S., "Structure of lactacystin, a new microbial metabolite which induces differentiation of neuroblastoma cells", Journal of Antibiotics, 44, pp.117~118 (1991)
  17. Pickart, C.M., "Mechanisms underlying ubiquitination", Annual Review of Biochemistry, 70, pp.503~533 (2001)
  18. Roccaro, A. M., "Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells", Cancer Research, 66, pp.184~191 (2006)
  19. Samuels-Lev, Y., "ASPP proteins specifically stimulate the apoptotic function of p53", Molecular Cell, 8, pp.781~794 (2001)
  20. Shah, S.A., "26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer", Journal of Cellular Biochemistry, 82, pp.110~122 (2001)
  21. Sun, Y., "Targeting E3 ubiquitin ligases for cancer therapy", Cancer Biology & Therapy, 2, pp.623~629 (2003)
  22. Van de Loosdrecht, A. A., "Cell mediated cytotoxicity against U937 cells by human monocytes and macrophages in modified colorimetric MTT assay", Journal of Immunological Methods, 141, pp.15~22 (1991)
  23. Wojcik, C., "Proteasomes in apoptosis: villains or guardians?", Cellular and Molecular Life Sciences, 56, pp.908~917 (1999)

관련 논문AI추천

Mode of Cell Death and Molecular Change of Oral Squamous Carcinoma Cells Exposed to Metal Ions김인령, 김형근, 김형일, 박창준, 박혜련대한구강생물학회 · International Journal of Oral Biology2006 · 제31권 제1호구강 편평세포암종 세포주에서 Cyclosporin A와 Taxol 투여시 PI-3 kinase/Akt1 Pathway에 의한 세포사멸 병용효과김규영, 이재훈대한구강악안면외과학회 · 대한구강악안면외과학회지2007 · 제33권 제5호Mechanism Underlying NaF-Induced Apoptosis in Human Oral Squamous Cell Carcinoma김도균, 김인령, 김지영, 박봉수, 이승은, 정나영, 허영주대한구강생물학회 · International Journal of Oral Biology2010 · 제35권 제2호Cyclosporin A가 구강편평상피세포암 세포주에 미치는 항암효과김경욱, 임한욱대한구강악안면외과학회 · 대한구강악안면외과학회지2004 · 제30권 제6호Augmentation of Sodium Butyrate-induced Apoptosis by Phosphatidylinositol 3-kinase Inhibition in the Human Cervical Cancer Cell-lineChi Heum Cho, Jung Kyu Park, Sabarish Ramachandran, Sang Hoon Kwon, So Jin Shin, Soon Do Cha, Sun Young Kwon대한암학회 · Cancer Research and Treatment2006 · 제38권 제2호Up-regulation of the DR5 Expression by Proteasome Inhibitor MG132 Augments TRAIL-Induced Apoptosis in Soft Tissue Sarcoma Cell Lines변재호, 우인숙, 원종호, 이규상, 정희정대한암학회 · Cancer Research and Treatment2011 · 제43권 제2호

이 간행물의 다른 논문 (4건)

Pharmacological and electrophysiological characterization of rat P2X currentsHai Ying Li, 김종수, 오석배pp. 1-5Effects of Panax ginseng and Ziziphus jujuba on stress-induced apoptosisin ratsHyung Chan Kimpp. 7-12Distribution of Taste Receptors in Submandibular and von Ebner SalivaryGlandsYong-Ku Jun, Se-Nyun Kim, Young-Kyung Cho, Ki-Myung Chung, Stephen D. Roper, Kyung-Nyun Kim, Cil-Han Leepp. 13-23High Extracellular Calcium Increased Expression of Ank, PC-1 andOsteopontin in Mouse Calvarial Cells송미나, 백정화, 류현모, 우경미, 김관식pp. 33-43
원문 보기